Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Quanterix Corporation - Common Stock (NQ:QTRX)

5.900 -0.050 (-0.84%)
Streaming Delayed Price Updated: 10:39 AM EST, Feb 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Quanterix Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Quanterix Releases Operating Results for Second Quarter 2023
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix to Present at Canaccord Genuity 43rd Annual Growth Conference
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix’s Simoa® Technology Powers Large, International Reference Range Study Utilizing Serum Neurofilament Light (sNfL) to Assess Neurological Disease Activity in Pediatric Patients
From Quanterix Corporation
Via Business Wire
News headline image
Recap: Quanterix Q1 Earnings ↗
 
Via Benzinga
News headline image
Quanterix's Return On Capital Employed Insights ↗
 
Via Benzinga
News headline image
Preview: Quanterix's Earnings ↗
 
Via Benzinga
News headline image
Quanterix to Report Second Quarter 2023 Financial Results on August 8, 2023
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Launches LucentAD Biomarker Blood Test to Aid Physician Diagnosis of Alzheimer’s Disease in Patients
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix to Participate in Fireside Chat at Goldman Sachs Annual Global Healthcare Conference
From Quanterix Corporation
Via Business Wire
News headline image
Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
Goldman Sachs Turns Bullish On Biotech With 'Significant Opportunity' ↗
Shares of Quanterix Corp (NASDAQ: QTRX) spiked in early trading on Tuesday and the stock is up almost 75% year to date. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2023 ↗
 
Via Benzinga
News headline image
Quanterix Releases Operating Results for First Quarter 2023
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix’s First Quarter 2023 Earnings Conference Call
From Quanterix Corporation
Via Business Wire
News headline image
FDA Accelerated Approval of Tofersen Highlights Importance of Blood Neurofilament Light Chain as Surrogate Endpoint in Neurology Therapeutic Trials
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix to Participate in Barclays Global Healthcare Conference
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Releases Operating Results for Fourth Quarter and Full Year 2022; Aligned with Expectations
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix to Present at Cowen’s 43rd Annual Health Care Conference
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Fourth Quarter Earnings and Full Year 2022 Financial Results Conference Call
From Quanterix Corporation
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
Quanterix Announces Appointment of Brian Blaser to Board of Directors
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Expands Laboratory Developed Test Menu with Launch of Neurofilament Light Chain Test
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix to Present at 41st Annual J.P. Morgan Healthcare Conference
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix’s Simoa® Technology Drives Advances in Alzheimer’s Disease Research Presented at 2022 Clinical Trials on Alzheimer’s Disease (CTAD) Conference
From Quanterix Corporation
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
Quanterix to Participate in the 15th Clinical Trials on Alzheimer’s Disease (CTAD) Task Force
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix to Participate in the Canaccord MedTech, Diagnostics and Digital Health & Services Forum
From Quanterix Corporation
Via Business Wire
News headline image
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
Quanterix Corporation Releases Operating Results for Third Quarter 2022
From Quanterix Corporation
Via Business Wire
News headline image
Earnings Preview For Quanterix ↗
Quanterix (NASDAQ:QTRX) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that Quanterix will... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.